Penserra Capital Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Buy |
12,786
+9,271
| +264% | +$104K | ﹤0.01% | 685 |
|
|
2025
Q1 | $20K | Buy |
3,515
+164
| +5% | +$933 | ﹤0.01% | 873 |
|
|
2024
Q4 | $32K | Buy |
3,351
+1,928
| +135% | +$18.4K | ﹤0.01% | 983 |
|
|
2024
Q3 | $11K | Buy |
1,423
+16
| +1% | +$124 | ﹤0.01% | 888 |
|
|
2024
Q2 | $19K | Buy |
1,407
+266
| +23% | +$3.59K | ﹤0.01% | 912 |
|
|
2024
Q1 | $52K | Sell |
1,141
-866
| -43% | -$39.5K | ﹤0.01% | 871 |
|
|
2023
Q4 | $134K | Buy |
2,007
+200
| +11% | +$13.4K | ﹤0.01% | 853 |
|
|
2023
Q3 | $130K | Sell |
1,807
-4,529
| -71% | -$326K | ﹤0.01% | 841 |
|
|
2023
Q2 | $470K | Buy |
6,336
+4,147
| +189% | +$308K | 0.01% | 540 |
|
|
2023
Q1 | $116K | Sell |
2,189
-133
| -6% | -$7.05K | ﹤0.01% | 759 |
|
|
2022
Q4 | $156K | Buy |
2,322
+1,757
| +311% | +$118K | ﹤0.01% | 734 |
|
|
2022
Q3 | $69K | Sell |
565
-1,029
| -65% | -$126K | ﹤0.01% | 778 |
|
|
2022
Q2 | $150K | Sell |
1,594
-784
| -33% | -$73.8K | ﹤0.01% | 710 |
|
|
2022
Q1 | $382K | Buy |
2,378
+383
| +19% | +$61.5K | 0.01% | 565 |
|
|
2021
Q4 | $661K | Buy |
1,995
+798
| +67% | +$264K | 0.01% | 468 |
|
|
2021
Q3 | $555K | Buy |
+1,197
| New | +$555K | 0.01% | 473 |
|